INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Braskem S.A. – BAK

NEW YORK, NY, NY / ACCESS Newswire / October 17, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Braskem S.A. ("Braskem" or the "Company") (NYSE:BAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Braskem and certain of its officers and/or directors […]

EZI, a Keeway Group Brand, Debuts at the 138th Canton Fair to Showcase Multi-Dimensional Strategy for E-Mobility Ecosystem Upgrade

Guangzhou, China, Oct. 17, 2025 (GLOBE NEWSWIRE) — EZI, a leading global electric light mobility solution brand under Keeway Group, made a striking appearance at the 138th China Import and Export Fair (Canton Fair), unveiling a lineup of self-developed electric vehicles under its brand philosophy “EZI, EASY GO.” The showcase emphasized Keeway Group's technology-driven product

No KYC. 100x Leverage. $100 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack

SINGAPORE, Oct. 17, 2025 (GLOBE NEWSWIRE) — With Bitcoin's price fluctuating below $110,000, many analysts predict a prolonged period of high volatility in the crypto market. Holding spot positions may struggle to generate short-term profits in such conditions. As a result, 100x leverage futures trading has become the preferred tool for seasoned investors looking to

Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025

(NasdaqGM:CRVS), Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) Interim data shows triplet therapy with ciforadenant, ipilimumab and nivolumab is feasible and well tolerated; longer follow-up with patients still on therapy needed to determine potential benefit of blocking adenosine

Broadway on 17th Sales Centre and Showhomes Now Open in Calgary’s Beltline

CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — Vesta Properties (Vesta) is pleased to announce the opening of the sales centre and two luxurious showhomes at Broadway on 17th, a landmark three-tower, 47-storey residential development in an iconic location in downtown Calgary. Located in the heart of the Beltline, Broadway on 17th is a master-planned

InboxAlly Unveils Expert-Developed 15-Step Pre-Send Email Marketing Checklist to Eliminate Costly Mistakes

New York, NY , Oct. 17, 2025 (GLOBE NEWSWIRE) — InboxAlly, the market's leading deliverability solution trusted by agencies, enterprises, and high-volume senders worldwide, today introduced its 15-Step Pre-Send Email Marketing Checklist authored by veteran email marketing strategist Jeanne Jennings, founder of Email Optimization Shop. Jeanne Jennings, veteran email marketing strategist, is the author of

A Great Idea Marks 10 Years with Music Collaboration and Microgrant Initiative

Durnham, North Carolina, Oct. 17, 2025 (GLOBE NEWSWIRE) — A Great Idea (AGI), the creative agency founded by strategist and designer Shane Lukas, announced the celebration of its 10th anniversary. Since its founding, AGI has partnered with mission-driven organizations and advocates to deliver creative strategies, design, and storytelling that support social change and community impact.

Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025

Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 GlobeNewswire October 17, 2025 Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with

Broadway on 17th Sales Centre and Showhomes Now Open in Calgary’s Beltline

Broadway on 17th Sales Centre and Showhomes Now Open in Calgary's Beltline Slated to be the city's tallest residential tower, the newly launched showhomes highlight the history, modern design and livability of the development GlobeNewswire October 17, 2025 CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — Vesta Properties (Vesta) is pleased to announce the opening

Artificial Lung Market to Grow at 10.84% CAGR, Hits USD 7.05 Bn by 2034

Artificial Lung Market to Grow at 10.84% CAGR, Hits USD 7.05 Bn by 2034 The artificial lung market size is calculated at USD 2.78 billion in 2025 and is expected to reach around USD 7.05 billion by 2034, growing at a CAGR of 10.84% for the forecasted period. GlobeNewswire October 17, 2025 Ottawa, Oct. 17,

Scroll to Top